Mirum Pharmaceuticals, Inc. — Investor Relations & Filings
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases, with a primary focus on debilitating liver conditions affecting both children and adults. The company's lead commercial product is LIVMARLI® (maralixibat), an oral solution for the treatment of cholestatic pruritus in patients with Alagille syndrome. Mirum's clinical pipeline is advancing other potential treatments, including volixibat, for various rare cholestatic liver diseases. The company's mission is to transform the treatment landscape for patients with significant unmet medical needs by advancing its scientific programs from discovery through commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-05-06 | English | |
| 8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-05-04 | English | |
| 8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-04-27 | English | |
| ARS - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-04-24 | English | |
| 8-K/A - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-04-08 | English |
Browse filings by year
9 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
Mirum Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31228/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31228 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31228 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31228 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31228}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Mirum Pharmaceuticals, Inc. (id: 31228)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.